Angebote zu "Cancer" (96 Treffer)

Innovative Endocrinology of Cancer als Buch von
200,49 € *
ggf. zzgl. Versand
(229,49 € / in stock)

Innovative Endocrinology of Cancer:Advances in Experimental Medicine and Biology. Auflage 2008

Anbieter: Hugendubel.de
Stand: 07.04.2018
Zum Angebot
Innovative Endocrinology of Cancer als Buch von
229,49 € *
ggf. zzgl. Versand
(229,49 € / in stock)

Innovative Endocrinology of Cancer:Advances in Experimental Medicine and Biology. Softcover reprint of hardcover 1st ed. 2008.

Anbieter: Hugendubel.de
Stand: 23.03.2018
Zum Angebot
Immunotherapy of Cancer - An Innovative Treatme...
154,69 € *
ggf. zzgl. Versand

This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy. This innovative therapy has been investigated worldwide as the fourth line of cancer treatment after the standard treatments of surgery, chemotherapy, and radiotherapy. The progress in fundamental understanding of tumor immunology and the recent advances in clinical trials have opened new avenues with a cancer vaccine in 2010 and immunocheckpoint modulation in 2011, with their approval already granted in the United States. Today, there are no doubts, even among experts in cancer chemotherapy and radiotherapy, that the immune system plays a vital role in tumor eradication. Following American approval, many clinical trials of cancer immunotherapy are being conducted. With this book the reader will readily understand the paradigm shift in cancer treatment and will realize the importance of cancer immunotherapy. The great value of immunotherapy will be obvious, not only for tumor shrinkage but for prolonging patient survival. Dr. Yoshiyuki Yamaguchi, MD, PhD, Professor, Department of Clinical Oncology, Kawasaki Medical School, Kurashiki, Japan

Anbieter: ciando eBooks
Stand: 02.04.2018
Zum Angebot
Cancer Immunology: Innovative Approaches to The...
200,49 € *
ggf. zzgl. Versand
(229,49 € / in stock)

Cancer Immunology: Innovative Approaches to Therapy:Cancer Treatment and Research. Auflage 1986

Anbieter: Hugendubel.de
Stand: 03.04.2018
Zum Angebot
Cancer Immunology: Innovative Approaches to The...
229,49 € *
ggf. zzgl. Versand
(229,49 € / in stock)

Cancer Immunology: Innovative Approaches to Therapy:Cancer Treatment and Research. Auflage 1986

Anbieter: Hugendubel.de
Stand: 23.03.2018
Zum Angebot
Innovative Endocrinology of Cancer als eBook Do...
171,99 € *
ggf. zzgl. Versand
(199,49 € / in stock)

Innovative Endocrinology of Cancer: N.N

Anbieter: Hugendubel.de
Stand: 06.04.2018
Zum Angebot
Radiotherapy in Prostate Cancer als Buch von
159,99 € *
ggf. zzgl. Versand
(159,99 € / in stock)

Radiotherapy in Prostate Cancer:Innovative Techniques and Current Controversies Medical Radiology Radiation Oncology. Auflage 2014

Anbieter: Hugendubel.de
Stand: 23.03.2018
Zum Angebot
Immunotherapy of Cancer als Buch von
146,49 € *
ggf. zzgl. Versand
(146,49 € / in stock)

Immunotherapy of Cancer:An Innovative Treatment Comes of Age. 1st ed. 2016

Anbieter: Hugendubel.de
Stand: 03.04.2018
Zum Angebot
Radiotherapy in Prostate Cancer als eBook Downl...
101,49 € *
ggf. zzgl. Versand
(101,49 € / in stock)

Radiotherapy in Prostate Cancer:Innovative Techniques and Current Controversies

Anbieter: Hugendubel.de
Stand: 06.04.2018
Zum Angebot
Novel Biomarkers in the Continuum of Breast Cancer
154,69 € *
ggf. zzgl. Versand

This volume provides a comprehensive review of established and novel biomarkers across the continuum of breast cancer. The volume covers topics related to breast cancer risk and prevention, prediction of response to todays standard therapies, and markers capable of influencing treatment decisions in the near future. Chapter authors combine their wide-ranging expertise to review the current status of the biomarker and to offer their individual perspectives on how biomarkers may be used in future treatments and research. Breast cancer continues to be the most common malignancy diagnosed in women in the Western world. While there are multiple treatment approaches for breast cancer, today more than ever we recognize that each tumor is unique. The challenge ahead is to consider how to best use validated and novel biomarkers to select the most appropriate treatment(s) for individual patients. Vered Stearns is a Professor of Oncology and the Co-Director of the Breast and Ovarian Cancer Program at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, where she also holds the Breast Cancer Research Chair in Oncology. Dr. Stearns is an expert in novel drug investigation-her long-term research goal is to improve current therapies by individualizing strategies for the treatment and prevention of breast cancer. Her main research includes utilization of biomarkers to predict response to standard regimens used to treat and prevent breast cancer and to introduce new treatments. While administering standard chemotherapy in the preoperative setting, Dr. Stearns examines molecular markers and functional imaging to assist in the early determination of sensitivity or resistance to different treatments. Dr. Stearns and colleagues from the Consortium On Breast Cancer Pharamcogenomics (COBRA) were the first to evaluate the role of genetic variants in candidate genes such as CYP2D6 in tamoxifen metabolism, safety, and efficacy. The work has been extended to evaluate the role of genetic variants in aromatase inhibitor-associated outcomes. Dr. Stearns, who received numerous grants and awards to fund her innovative research, was a recipient of early career awards, including a Clinical Research Training Grant from the American Cancer Society, and was one of the first five recipients of the prestigious Damon Runyon Clinical Investigator Award. Subsequently, she was the inaugural recipient of the American Society of Clinical Oncologys Advanced Clinical Research Award. She is an Editorial Board Member of Clinical Cancer Research, Breast Cancer Research and Treatment, and ONCOLOGY. Dr. Stearns work has been presented in key national and international meetings. She has published more than 150 scientific publications, which have been cited extensively.

Anbieter: ciando eBooks
Stand: 02.04.2018
Zum Angebot